Back to Search

ASHISH CHAKRAVARTHY, MD

MD

Emergency Medicine Physician

NPI: 1275589145Individual

Specialties, Licenses & Credentials

Emergency Medicine PhysicianPrimary

Emergency Medicine

Code: 207P00000X

030804(TN)

Research & Publications (15)

A phase I trial of outpatient weekly irinotecan/carboplatin and concurrent radiation for stage III unresectable non small-cell lung cancer: a Vanderbilt-Ingram Cancer Center Affiliate Network Trial.
PMID 14733637·Clin Lung Cancer·2000
8-other
Temporal sampling requirements for reference region modeling of DCE-MRI data in human breast cancer.
PMID 19557727·J Magn Reson Imaging·2009
8-other
A nonrigid registration algorithm for longitudinal breast MR images and the analysis of breast tumor response.
PMID 19525078·Magn Reson Imaging·2009
8-other
SU11248 (sunitinib) sensitizes pancreatic cancer to the cytotoxic effects of ionizing radiation.
PMID 18514780·Int J Radiat Oncol Biol Phys·2008
8-other
Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: a multicenter phase II trial.
PMID 18281668·J Clin Oncol·2008
3-trial
Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results.
PMID 17222711·Magn Reson Imaging·2007
8-other
Neoadjuvant concurrent paclitaxel and radiation in stage II/III breast cancer.
PMID 16533783·Clin Cancer Res·2006
8-other
Post-mastectomy radiation in male breast cancer.
PMID 12443805·Radiother Oncol·2002
8-other
Radiation therapy for non-small cell lung cancer (NSCLC).
PMID 11224985·Cancer Treat Res·2001
4-observational
Radiation-mediated control of drug delivery.
PMID 11586099·Am J Clin Oncol·2001
6-review
Targeting drug delivery to radiation-induced neoantigens in tumor microvasculature.
PMID 11489494·J Control Release·2001
8-other
A pilot study of neoadjuvant paclitaxel and radiation with correlative molecular studies in stage II/III breast cancer.
PMID 11899393·Clin Breast Cancer·2000
8-other
Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival.
PMID 11072167·Int J Radiat Oncol Biol Phys·2000
8-other
Weekly irinotecan and concurrent radiation therapy for stage III unresectable NSCLC.
PMID 10981290·Oncology (Williston Park)·2000
6-review
Molecular analysis of autosomal dominant hereditary ataxias in the Indian population: high frequency of SCA2 and evidence for a common founder mutation.
PMID 10746559·Hum Genet·2000
8-other

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
1260 UNIVERSITY AVE
SEWANEE, TN 37375

Location

Practice Location

1260 UNIVERSITY AVE, SEWANEE, TN
(931) 598-5691

Quick Facts

NPI
1275589145
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
15

Are you this provider?

Claim Your Profile